Press release
Bleeding Disorders Market Set to Reach $26+ Billion by 2032: Innovations and Collaborations Enhance Patient Outcomes
Bleeding Disorders Market Size, Share, Competitive Landscape
The global bleeding disorders market is on a significant upward trajectory, projected to expand from $13.8 billion in 2022 to an impressive $26 billion by 2032. This represents a compound annual growth rate (CAGR) of 6.6% from 2023 to 2032. Below are some key insights into the market's growth drivers, segmental overview, and competitive landscape.
Understanding Bleeding Disorders
• Definition: Bleeding disorders impair the body's ability to form blood clots, which are crucial for stopping bleeding.
• Common Types: The major types include:
• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Other rare bleeding disorders
• Diagnosis: Blood tests and genetic testing are used to diagnose these conditions.
• Treatment Options:
• Plasma-derived coagulation factor concentrates
• Recombinant coagulation factor concentrates
• Desmopressin
• Antifibrinolytics
• Fibrin sealants
Market Dynamics
Several factors are fueling the growth of the bleeding disorders market:
• Rising Incidence:
• An increase in diagnosed cases of bleeding disorders due to improved awareness and diagnostic techniques.
• Approximately 400,000 individuals globally have severe hemophilia.
• Funding and Research:
• Increased funding from organizations like the Hemophilia Federation of America (HFA) to support patients and their families.
• Scholarships and initiatives, such as the "Together Project" by the National Hemophilia Foundation and HFA, focus on reducing the burden of hemophilia.
• Clinical Trials and Innovations:
• A rise in clinical trials and research activities, including the Phase 4 clinical trial of IXINITY for pediatric hemophilia B patients, is paving the way for new treatments.
• Awareness in Developing Countries:
• Growing awareness about bleeding disorders in developing nations is expected to boost market growth.
Segmental Overview
By Disease Type
• Hemophilia A:
• Generated the highest revenue in 2022.
• Expected to witness the highest CAGR due to increasing cases and research efforts.
• Hemophilia B & Von Willebrand Disease:
• Contribute to market growth but at a slower rate compared to hemophilia A.
By Treatment Type
• Factor Replacement Therapy:
• Dominated the market in 2022 due to high demand and an increase in clotting factor-deficient diseases.
• Anticipated to maintain the highest CAGR as research and clinical trials increase.
• Drug Therapy:
• Includes desmopressin and antifibrinolytics, contributing to the overall market share.
By Distribution Channel
• Retail Pharmacies:
• Led the market in 2022, reflecting the common preference for obtaining medications from these outlets.
• Hospital Pharmacies:
• Expected to experience the highest growth, offering tailored medications based on individual patient needs.
By Region
• North America:
• Held a significant market share in 2022 and is projected to continue leading, driven by the presence of major pharmaceutical companies like Pfizer and Medexus Pharma.
• Asia-Pacific:
• Expected to exhibit the highest growth rate, attributed to increasing incidences of hemophilia and improving purchasing power in countries like China and India.
Competitive Landscape
The bleeding disorders market features several key players, including:
• Bayer AG
• CSL Behring
• F. Hoffmann-La Roche AG
• Grifols, S.A.
• Medexus Pharma, Inc.
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi Corporation
• Takeda Pharmaceutical Company Limited
Strategic Developments
• Investment and Partnerships: Major players are engaging in investments, partnerships, and product approvals to enhance their market presence and product portfolios.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/2801
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
AMR launched its user-based online library of reports and company profiles Avenue. An e-access library is accessible from any device anywhere and at any time for entrepreneur's stakeholder's researchers and students at universities. With reports on more than 60000 niche markets with data comprising of 600000 pages along with company profiles on more than 12000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients' requirements is complemented with analyst support and customization requests.
Contact:
David Correa
5933 NE Win Sivers Drive
#205 Portland OR 97220
United States
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn and Twitter
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bleeding Disorders Market Set to Reach $26+ Billion by 2032: Innovations and Collaborations Enhance Patient Outcomes here
News-ID: 3680150 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Bleeding
Growth Of Bleeding Disorder Testing Market Driven By Increasing Clinical Trials: …
The Bleeding Disorder Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bleeding Disorder Testing Market?
The bleeding disorder testing market size has increased strongly in recent years. It will rise from $14.99 billion in 2024 to $16.23 billion…
Rise In The Incidences Of Upper Gastrointestinal Bleeding: Key Factor Driving Th …
The Gastrointestinal Bleeding Treatment Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Gastrointestinal Bleeding Treatment Devices Market Size During the Forecast Period?
Recent years have seen a robust growth in the market size of devices used in the treatment of gastrointestinal…
Key Trend Reshaping the Bleeding Disorder Testing Market in 2025: Innovative Gen …
What industry-specific factors are fueling the growth of the bleeding disorder testing market?
The bleeding disorder testing market is poised for growth, buoyed by the rise in clinical trials. Clinical trials, which test the safety and efficiency of new medical care methods, therapies, drugs, or technology in humans, are increasing due to advancements in medical research, more healthcare innovation investment, and an upsurge in demand for novel treatments and therapies. Bleeding…
Transforming the Bleeding Disorder Testing Market in 2025: Growth Of Bleeding Di …
What Is the Expected Size and Growth Rate of the Bleeding Disorder Testing Market?
The market size for bleeding disorder testing has witnessed robust growth in recent years. The market value is projected to increase from $14.99 billion in 2024 to a whopping $16.23 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The rate of growth recorded in the historic period is associated with factors such as…
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of…
Global Cyclic Heavy Menstrual Bleeding Market
Global Cyclic Heavy Menstrual Bleeding Market
Heavy menstrual bleeding (HMB) is one of the most common debilitating gynecologic disorders that is affecting women of reproductive age. Increasing incidence rate drives the growth of the cyclic heavy menstrual bleeding market. Rising cases of uterine fibroids and polyps boost the growth of cyclic heavy menstrual bleeding. In addition, effective treatment cost and easy availability of treatment options plays a significant role in…
